Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1697P - Cancer patients’ perceptions, opinions and feelings during the COVID-19 epidemic in the most affected Italian areas: Serial cross-sectional study

Date

17 Sep 2020

Session

E-Poster Display

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Rodolfo Passalacqua

Citation

Annals of Oncology (2020) 31 (suppl_4): S934-S973. 10.1016/annonc/annonc289

Authors

R. Passalacqua1, G. Maglietta2, M. Ratti3, A. Gobbi4, M. Bonomi4, J. Saleri4, G. Grizzi1, F. Barbin4, L. BONASSI5, L. Buffoni6, L. Cavanna7, F. Gallina8, E. Gervasi9, C. Iridile10, V. Lonati11, R. Maddalena12, F.A. Meriggi13, S. PILONI14, F. Campione15, C. Caminiti2

Author affiliations

  • 1 Oncology, ASST Cremona, 26100 - Cremona/IT
  • 2 Ricerca E Innovazione, AOU PARMA, 43126 - PARMA/IT
  • 3 Dipartimento Di Oncologia, Istituti Ospitalieri di Cremona, 26100 - Cremona/IT
  • 4 Oncology, ASST Cremona, 26100 - cremona/IT
  • 5 Oncology, ASST BERGAMO EST, 24022 - ALZANO LOMBARDO/IT
  • 6 Oncology, Humanitas Gradenigo, 10153 - Torino/IT
  • 7 Oncology Department, Azienda Ospedaliera Piacenza, 29121 - Piacenza/IT
  • 8 Oncology, ASST MONZA, 20900 - MONZA/IT
  • 9 Oncology, AUSL-IRCCS Reggio Emilia, 42123 - Reggio Emilia/IT
  • 10 Oncology, ASST MANTOVA, 46100 - MANTOVA/IT
  • 11 Oncology, ASST BERGAMO OVEST, 24047 - Treviglio/IT
  • 12 Oncology, ASST VIMERCATE, 20871 - VIMERCATE/IT
  • 13 Oncology, Fondazione Poliambulanza, 25124 - BRESCIA/IT
  • 14 Oncology, ASST Crema, 26013 - crema/IT
  • 15 Medicina E Chirurgia, Università di Bologna, 40126 - BOLOGNA/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1697P

Background

Risks associated with COVID outbreak and consequent restrictive measures taken by the Government can cause concern and anxiety. The impact on cancer patients (pts) may be even greater. We investigated the influence of COVID pandemic on pts’ perceptions, opinions and feelings during the peak of the epidemic and after the loosening of the Government restrictions.

Methods

Multicenter, serial cross-sectional study conducted in 11 cancer centers located in the hardest hit Italian areas. The study is composed by 2 surveys administered to unselected adult pts receiving onsite oncologic treatments: the first during the enforcement of containment measures against COVID spread; the second upon the loosening of Government restrictions. A self-administered questionnaire composed by 11 closed questions (only 1 answer) was used. At least 1000 pts per each survey were deemed necessary. Multivariable logistic regression models will be used to identify factors associated to recorded perceptions and opinions. Main outcomes are: 1) perception of the pandemic effect on feelings 2) perception of changes in the relationship with the medical team 3) opinions on healthcare reorganization and on the information campaign This study has been approved by all Ethical Commettees of the centers.

Results

The first survey was conducted between March 16th and April 30th. 1027 questionnaires were collected. Mean age was 64 yrs (SD 11.7), 58% were women, 49% had low educational level. 80% and 20% received i.v. and oral treatment, respectively. As for pts feelings, 45.5% indicated that their fears related to cancer increased because hope in recovery diminished (23%). Courage of coping with tumor was increased in 26%, unchanged in 64%; 95% perceived a high availability of healthcare facilities and 97.6% declared confidence in the treating teams, while 65.3% stated that the information received from the Government and local bodies was confusing.

Conclusions

Although half of the pts had more fears and concerns about the epidemic, they feel reassured, maintain trust in healthcare facilities and a good communication with doctors and nurses. Due to the epidemic course, the second survey could not yet be performed and data will be available by June.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Azienda Istituti Ospitalieri di Cremona, Italy.

Funding

MEDEA, Medicina e Arte, Onlus, Cremona.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.